---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005020"
form_type: "8-K"
ticker: "DTSQ"
cik: "0002017950"
company_name: "DT Cloud Star Acquisition Corp"
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T05:05:32.766802+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# DT Cloud Star to merge with PrimeGen US in $1.5B SPAC deal; target advances stem cell therapy

## Summary
- Deal implies ~$1.5B equity value for PrimeGen US; expected to close in H2 2026 subject to approvals.
- PrimeGen's Triple Activated MSC platform targets acute liver failure; completed FDA Pre-IND meeting Dec 17, 2025.
- Combined company to list on Nasdaq under a new ticker; proceeds to fund clinical development and commercialization.
- Transaction requires stockholder approvals, HSR clearance, and minimum cash conditions; closing not guaranteed.

## SEC filing metadata
- accession: 0001493152-26-005020
- form_type: 8-K
- ticker: DTSQ
- cik: 0002017950
- company_name: DT Cloud Star Acquisition Corp
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2017950/000149315226005020/0001493152-26-005020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2017950/000149315226005020/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005020
- JSON: https://secwatch.observer/filing/0001493152-26-005020.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.